2022
Medication Use for Obesity-Related Comorbidities After Sleeve Gastrectomy or Gastric Bypass
Howard R, Chao G, Yang J, Thumma J, Arterburn D, Telem D, Dimick J. Medication Use for Obesity-Related Comorbidities After Sleeve Gastrectomy or Gastric Bypass. JAMA Surgery 2022, 157: 248-256. PMID: 35019988, PMCID: PMC8756362, DOI: 10.1001/jamasurg.2021.6898.Peer-Reviewed Original ResearchConceptsTime of surgeryGastric bypassMedication discontinuationSleeve gastrectomyCumulative incidenceMedication useHyperlipidemia medicationsComorbidity resolutionLower incidenceCommon bariatric surgical proceduresLipid-lowering medication useComparative effectiveness research studyAdult Medicare beneficiariesDiabetes medication useAntihypertensive medication useLipid-lowering medicationsBariatric surgical proceduresSubset of patientsLong-term trialsAntihypertensive medicationsDiabetes medicationsLaparoscopic RouxBariatric surgeryPrimary outcomeMean age
2021
Comparative Safety of Sleeve Gastrectomy and Gastric Bypass Up to 5 Years After Surgery in Patients With Severe Obesity
Howard R, Chao G, Yang J, Thumma J, Chhabra K, Arterburn D, Ryan A, Telem D, Dimick J. Comparative Safety of Sleeve Gastrectomy and Gastric Bypass Up to 5 Years After Surgery in Patients With Severe Obesity. JAMA Surgery 2021, 156: 1160-1169. PMID: 34613354, PMCID: PMC8495604, DOI: 10.1001/jamasurg.2021.4981.Peer-Reviewed Original ResearchConceptsAdjusted hazard ratioSleeve gastrectomyGastric bypassRisk of mortalityCumulative incidenceLong-term riskBariatric surgerySurgical revisionComparative safetyMAIN OUTCOMEUnknown raceLower long-term riskHigher long-term riskUnderwent sleeve gastrectomyRetrospective cohort studyEmergency department useHealth care useLong-term safetyMedicare claims databaseTotal health care spendingCause hospitalizationLaparoscopic RouxCohort studyHazard ratioSecondary outcomes